Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.
作者信息
Chen Guang, Henter Ioline D, Manji Husseini K
机构信息
Janssen Pharmaceutical Research & Development, Johnson & Johnson, San Diego, California.
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
出版信息
Biol Psychiatry. 2014 Jul 15;76(2):86-8. doi: 10.1016/j.biopsych.2014.05.005.
Abstract
摘要
相似文献
1
Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.展望未来：视网膜电图异常、糖原合酶激酶-3与神经精神疾病的生物标志物
Biol Psychiatry. 2014 Jul 15;76(2):86-8. doi: 10.1016/j.biopsych.2014.05.005.
2
Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.糖原合酶激酶-3 过表达复制了精神分裂症和双相情感障碍高遗传风险后代的视网膜电图异常。
Biol Psychiatry. 2014 Jul 15;76(2):93-100. doi: 10.1016/j.biopsych.2013.08.035. Epub 2013 Oct 17.
3
Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?超越糖原合酶激酶-3基因表达对视网膜电图反应的作用：锂呢？
Biol Psychiatry. 2015 Feb 1;77(3):e15-e17. doi: 10.1016/j.biopsych.2014.07.024. Epub 2014 Aug 1.
4
GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.GSK-3β 多态性可区分双相情感障碍和精神分裂症：系统荟萃分析。
Mol Neurobiol. 2013 Dec;48(3):404-11. doi: 10.1007/s12035-013-8414-x. Epub 2013 Feb 27.
5
No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.韩国人群中，GSK-3β基因多态性-1727A/T、-50C/T位点的两个常见单核苷酸多态性与精神分裂症和双相情感障碍无关联。
Neurosci Lett. 2006 Mar 6;395(2):175-8. doi: 10.1016/j.neulet.2005.10.059. Epub 2005 Nov 14.
6
Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.双相情感障碍和精神分裂症患者死后大脑中糖原合酶激酶-3β和β-连环蛋白的区域特异性失调
Bipolar Disord. 2015 Mar;17(2):160-71. doi: 10.1111/bdi.12228. Epub 2014 Jul 8.
7
Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
Psychiatr Genet. 2007 Aug;17(4):249-50. doi: 10.1097/YPG.0b013e328013d8d8.
8
Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.GSK-3β基因T-50C多态性与精神分裂症和双相情感障碍的关联分析。
Neuropsychobiology. 2006;53(1):51-6. doi: 10.1159/000090704. Epub 2006 Jan 4.
9
Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.双相情感障碍患者糖原合酶激酶-3β基因多态性与预防性锂反应的关联研究。
World J Biol Psychiatry. 2006;7(3):158-61. doi: 10.1080/15622970600554711.
10
Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.糖原合酶激酶 3β 基因结构变异可能是双相抑郁症的风险因素。
Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):217-22. doi: 10.1002/ajmg.b.32223. Epub 2014 Feb 21.
引用本文的文献
1
Optical Coherence Tomography Findings in Bipolar Disorder Patients and the Related Factors.双相情感障碍患者的光学相干断层扫描结果及相关因素
Psychiatry Clin Psychopharmacol. 2023 Dec 1;33(4):254-263. doi: 10.5152/pcp.2023.23687. eCollection 2023 Dec.
2
Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography.视网膜作为精神分裂症谱系障碍的潜在生物标志物：光学相干断层扫描和视网膜电图的系统评价和荟萃分析。
Mol Psychiatry. 2024 Feb;29(2):464-482. doi: 10.1038/s41380-023-02340-4. Epub 2023 Dec 11.
3
Subsequent and simultaneous electrophysiological investigation of the retina and the visual cortex in neurodegenerative and psychiatric diseases: what are the forecasts for the medicine of tomorrow?神经退行性疾病和精神疾病中视网膜与视觉皮层的后续及同步电生理研究：对未来医学有何展望？
Front Psychiatry. 2023 Jun 2;14:1167654. doi: 10.3389/fpsyt.2023.1167654. eCollection 2023.
本文引用的文献
1
Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.糖原合酶激酶-3 过表达复制了精神分裂症和双相情感障碍高遗传风险后代的视网膜电图异常。
Biol Psychiatry. 2014 Jul 15;76(2):93-100. doi: 10.1016/j.biopsych.2013.08.035. Epub 2013 Oct 17.
2
An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.Wnt 和 GSK3 信号通路在精神分裂症中的新作用。
Clin Genet. 2013 Jun;83(6):511-7. doi: 10.1111/cge.12111. Epub 2013 Apr 1.
3
GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder.GSK-3 和 Wnt 信号在神经发生和双相情感障碍中的作用。
Front Mol Neurosci. 2012 Jan 30;5:1. doi: 10.3389/fnmol.2012.00001. eCollection 2012.
4
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.抑制糖原合酶激酶-3是氯胺酮对小鼠产生快速抗抑郁作用所必需的。
Mol Psychiatry. 2011 Nov;16(11):1068-70. doi: 10.1038/mp.2011.47. Epub 2011 Apr 19.
5
Is glycogen synthase kinase-3 a central modulator in mood regulation?糖原合酶激酶-3 是否是情绪调节的核心调节剂？
Neuropsychopharmacology. 2010 Oct;35(11):2143-54. doi: 10.1038/npp.2010.105. Epub 2010 Jul 28.
6
GSK3 signalling in neural development.GSK3 信号在神经发育中的作用。
Nat Rev Neurosci. 2010 Aug;11(8):539-51. doi: 10.1038/nrn2870.
7
A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.一种驱动蛋白信号复合物介导了 GSK-3β影响情绪相关行为的能力。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11573-8. doi: 10.1073/pnas.0913138107. Epub 2010 Jun 7.
8
DISC1 partners with GSK3beta in neurogenesis.在神经发生过程中，DISC1与糖原合成酶激酶3β相互作用。
Cell. 2009 Mar 20;136(6):990-2. doi: 10.1016/j.cell.2009.03.005.
9
Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway.靶向信号转导通路治疗情绪障碍：Wnt通路相关性的最新见解
CNS Neurol Disord Drug Targets. 2007 Jun;6(3):193-204. doi: 10.2174/187152707780619308.
10
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.生物标志物与替代终点：首选定义及概念框架
Clin Pharmacol Ther. 2001 Mar;69(3):89-95. doi: 10.1067/mcp.2001.113989.
Zotero 插件